This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Ebola Virus Disease
and you are
over 1
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the safety and immunogenicity of three vaccine strategies that may prevent Ebola virus disease (EVD) events in children and adults. Participants will receive either the Ad26.ZEBOV (rHAd26) vaccine with a MVA-BN-Filo (MVA) boost, or the rVSVΔG-ZEBOV-GP (rVSV) vaccine with or without boosting, or placebo.

Provided treatments

  • Biological: Ad26.ZEBOV
  • Biological: MVA-BN-Filo
  • Biological: rVSVΔG-ZEBOV-GP
  • Biological: Placebo
  • Biological: rVSV boost

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02876328. The sponsor of the trial is National Institute of Allergy and Infectious Diseases (NIAID) and it is looking for 4789 volunteers for the current phase.
Official trial title:
Partnership for Research on Ebola VACcinations (PREVAC)